Bank of Montreal’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-4,002
Closed -$20K 4746
2020
Q1
$20K Buy
4,002
+4,000
+200,000% +$35.1K ﹤0.01% 3248
2019
Q4
$0 Sell
2
-5,000
-100% -$29.3K ﹤0.01% 4939
2019
Q3
$27K Buy
5,002
+5,000
+250,000% +$29.2K ﹤0.01% 3922
2019
Q2
$0 Sell
2
-1
-33% -$7 ﹤0.01% 4998
2019
Q1
$0 Hold
3
﹤0.01% 4563
2018
Q4
$0 Buy
3
+1
+50% +$4 ﹤0.01% 4766
2018
Q3
$0 Buy
2
+1
+100% +$9 ﹤0.01% 4832
2018
Q2
$0 Hold
1
﹤0.01% 4808
2018
Q1
$0 Hold
1
﹤0.01% 4258
2017
Q4
$0 Hold
1
﹤0.01% 4261
2017
Q3
$0 Sell
1
-1,067
-100% -$18.8K ﹤0.01% 4259
2017
Q2
$23K Sell
1,068
-267
-20% -$14.7K ﹤0.01% 3485
2017
Q1
$116K Buy
1,335
+1,334
+133,400% +$117K ﹤0.01% 2747
2016
Q4
$0 Hold
1
﹤0.01% 4137
2016
Q3
$0 Hold
1
﹤0.01% 4122
2016
Q2
$0 Hold
1
﹤0.01% 4226
2016
Q1
$1K Hold
1
﹤0.01% 4079
2015
Q4
$1K Buy
+1
New +$734 ﹤0.01% 4098
2015
Q3
Hold
0
4084
2015
Q2
Hold
0
4043
2015
Q1
Hold
0
4115
2014
Q4
Hold
0
4109
2014
Q3
Hold
0
4237
2014
Q2
Hold
0
4763
2014
Q1
Hold
0
4092
2013
Q4
Hold
0
3839
2013
Q3
Hold
0
3873
2013
Q2
Hold
0
3656

Other funds holding MBOT

Bank of Montreal's MBOT Position: Q2 2020 in Review

Bank of Montreal sold out of Microbot Medical (MBOT) in Q2 2020, closing a stake of 4,002 shares — an estimated $20K sold.

Bank of Montreal first reported a position in MBOT in Q4 2015 and held it in 18 quarters. The position peaked at $116K in Q1 2017. 23 funds tracked by Wall St. Rank hold MBOT as of Q2 2020.

  • Bank of Montreal reported no remaining Microbot Medical position as of Q2 2020 after selling out during the quarter.
  • Bank of Montreal sold 4,002 Microbot Medical shares in Q2 2020, an estimated $20K.
  • Bank of Montreal first reported a position in Microbot Medical in Q4 2015 and held it in 18 quarters.
  • Bank of Montreal's Microbot Medical position peaked at $116K in Q1 2017.
  • 23 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2020.

Based on Bank of Montreal's 13F filing for Q2 2020, filed 12 Aug 2020.